Table 2.
Regression analyses examining the role of 3-month IPV individually and as a moderator on 12-month depressive symptoms for EUC
| Enhanced usual care arm (N = 115) | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | ||||||||||||||||
| R square = 0.045 (ns) | R square = 0.08 (ns) | R square = 0.089 (ns) | ||||||||||||||||
| Predictors | B | Std. error | Beta | t | Sig | % unique variance | B | Std. error | Beta | t | Sig | % unique variance | B | Std. error | Beta | t | Sig | % unique variance |
| Constant | 1.36 | 5.90 | 0.23 | 0.82 | 0.18 | 5.84 | 0.03 | 0.97 | − 0.24 | 5.85 | − 0.04 | 0.97 | ||||||
| Age | 0.10 | 0.08 | 0.12 | 1.26 | 0.21 | 1.36 | 0.13 | 0.08 | 0.16 | 1.65 | 0.10 | 2.27 | 0.13 | 0.08 | 0.16 | 1.70 | 0.09 | 2.42 |
| Baseline depressive symptoms | 0.27 | 0.30 | 0.09 | 0.93 | 0.35 | 0.74 | 0.20 | 0.29 | 0.06 | 0.69 | 0.49 | 0.40 | 0.21 | 0.29 | 0.07 | 0.72 | 0.47 | 0.43 |
| 3-month activation | − 0.33 | 0.18 | − 0.18 | − 1.84 | 0.07 | 2.92 | − 0.29 | 0.18 | − 0.16 | − 1.67 | 0.10 | 2.32 | − 0.47 | 0.24 | − 0.26 | − 1.93 | 0.06 | 3.13 |
| 3-month IPV | N/A | 3.01 | 1.46 | 0.19 | 2.06 | 0.04 | 3.55 | 3.43 | 1.51 | 0.22 | 2.27 | 0.03 | 4.29 | |||||
| 3-month activation*IPV | N/A | 0.36 | 0.34 | 0.14 | 1.06 | 0.29 | 0.94 | |||||||||||